QUESTCOR PHARMACEUTICALS INC's ticker is QCOR and the CUSIP is 74835Y101. A total of 288 filers reported holding QUESTCOR PHARMACEUTICALS INC in Q3 2013. The put-call ratio across all filers is 2.38 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2014 | $2,774,000 | -69.6% | 29,984 | -78.7% | 0.00% | -75.0% |
| Q1 2014 | $9,132,000 | +38.7% | 140,637 | +16.3% | 0.00% | +33.3% |
| Q4 2013 | $6,585,000 | -5.0% | 120,926 | +1.2% | 0.00% | 0.0% |
| Q3 2013 | $6,929,000 | +37.1% | 119,470 | +7.4% | 0.00% | 0.0% |
| Q2 2013 | $5,054,000 | – | 111,211 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,296,660 | $149,800,000 | 34.05% |
| Valiant Capital Management, L.P. | 913,693 | $41,518,000 | 4.98% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 366,625 | $16,659,000 | 4.35% |
| Freshford Capital Management, LLC | 575,000 | $26,128,000 | 3.87% |
| Palo Alto Investors LP | 696,297 | $31,640,000 | 3.73% |
| RIVULET CAPITAL, LLC | 100,000 | $4,544,000 | 3.62% |
| CAPITAL MANAGEMENT CORP /VA | 190,135 | $8,640,000 | 3.59% |
| Consonance Capital Management LP | 200,000 | $9,088,000 | 3.23% |
| DIALECTIC CAPITAL MANAGEMENT, LP | 407,400 | $18,513,000 | 2.70% |
| Freestone Capital Holdings, LLC | 268,738 | $12,211,000 | 2.50% |